Schering Plough Articles
S-P extends HuCAL access deal with MorpoSys
26 May 2008
Pharma M&A rumor mill in top gear
26 May 2008
New effort to curb DTC ads by US Democrats
12 May 2008
Merck & Co shares fall 5.1% after
5 May 2008
No to Merck & Co/S-P combo allergy drug
5 May 2008
Similar SVRs for S-P and Roche HCV combos
5 May 2008
S-P's boceprevir sees 57% SVR at 28 weeks
5 May 2008
S-P profit down, sales up on Organon buy
5 May 2008
Merck & Co 1Q results saved by AZ payout
28 April 2008
Schering-Plough to deliver Hep C data
28 April 2008
IFPMA chief retires; new DG to be confirmed
21 April 2008
S-P's Aerius gets expanded EU label
21 April 2008
Stock Commentary - New York week to April 7, 2008
14 April 2008
Schering-Plough plans $1.5B cost cuts due to market pressures and cholesterol drug woes
7 April 2008
Stock Commentary - New York week to March 31, 2008
7 April 2008
Crestor sales hopes raised by JUPITER trial
7 April 2008
Zetia "could be expensive placebo," ACC hears
7 April 2008
Mylan seeks more generic market share
7 April 2008
Stock Commentary - New York week to March 24, 2008
31 March 2008
Centocor and S-P submit MAA on golimumab
24 March 2008
OctoPlus' Locteron impresses in Ph I study
17 March 2008
S-P files Zegrid OTC NDA with FDA
17 March 2008
CHMP advises labeling change for S-P
17 March 2008
Stock Commentary - New York week to March 3, 2008
10 March 2008
UCB's Cimzia effective in treatment refractory CD
10 March 2008
Centocor's psoriasis drug accepted for FDA review
10 March 2008
AstraZeneca to appeal $215M Ala damages
3 March 2008
NWBT's DCVax impresses in Phase I/II studies
25 February 2008
Doctors claim statins cause memory loss
25 February 2008
Jacqueline Elbonne named as VP of global research quality at SPRI
18 February 2008
Schering-Plough/OraSure in hep C test accord
18 February 2008
Ustekinumab: "gold standard" for psoriasis by 2011
18 February 2008
US congressional committee widens Vytorin investigation
18 February 2008
S-P's 4th-qtr 2007 results hit by Organon buy
18 February 2008
S-P's vicriviroc suppresses HIV load through 48 weeks
18 February 2008
FDA approves S-P's Asmanex Twisthaler
14 February 2008
OctoPlus begins dosing in US Locteron study
11 February 2008
Stock Commentary - New York week to Feb 4, 2008
11 February 2008
US IDSA's IFI guidelines recommend S-P's Noxafil
11 February 2008
Stock Commentary - New York week to Jan 28, 2008
4 February 2008
IFPMA increases assistance to WHO-based TDR program
4 February 2008
Japan stock market week to Jan 28, 2008
4 February 2008
Vioxx costs see Merck & Co swing to $1.6B loss
4 February 2008
S-P/Merck & Co account for ENHANCE delay
4 February 2008
S-P's Peg-IFN gets US FDA priority review
4 February 2008
UK's NICE gives go ahead on S-P's Remicade and Lilly's Alimta
28 January 2008
Stock Commentary - New York week to Jan 21, 2008
28 January 2008
Pharma majors enter CSN experimental medicines consortium
28 January 2008
Drugmakers accused of delaying ENHANCE data
28 January 2008
US clinic ships 19,000 drug firm gifts to Cameroon
28 January 2008
Sugammdex filed with Japan's MHLW
28 January 2008
Christian Deleuze and Michael Seeley join LEEM
14 January 2008
Stock Commentary - New York week to Jan 7, 2008
14 January 2008
Cash shortfall delays trial of Novacea's AQ4N
14 January 2008
US Public Citizen group sues the FDA over antibiotics warnings
14 January 2008
S-P's sugammadex NDA gets priority status
14 January 2008
Schering-Plough/Centocor revise Remicade and golimumab deals
7 January 2008
AZD6244 falls short in Ph II skin cancer study
7 January 2008
S-P "blocked Subutex generic" in France
17 December 2007
PhRMA details Mexico flood relief by members
17 December 2007
US FDA accepts NDA for S-P's asenapine
10 December 2007
FDA panel recommends warning on salmeterol
10 December 2007
Headlines 25 years ago this week....
3 December 2007
S-P buys Organon for 11B euros
26 November 2007
ENHANCE data now expected March 2008
26 November 2007
Further EU approval for S-P's HCV drug combo
26 November 2007
FTC clears Schering-Plough buy of Organon
26 November 2007
Pegintron plus Rebetol achieves consistent SVR
21 November 2007
Survey sees growing pharmaceutical industry contribution to developing world health
21 November 2007
US court doubles AZ and B-MS damages
21 November 2007
Xoma posts $22M third quarter profit
19 November 2007
Organon's asenapine improves PANSS score in schizophrenics
19 November 2007
Reverse payment ban stalls in US Congress
19 November 2007
"Devastating" AS ruling by the NICE condemned
19 November 2007
Schering-Plough subsid Warrick "no effect" on Medicaid
12 November 2007
Novacea stops Ph III Asentar trial
12 November 2007
Stock Commentary - New York week to Oct 29, 2007
5 November 2007
Headlines 25 years ago this week....
5 November 2007
Endotis acquires three Organon antithrombics
5 November 2007
S-P's Temodar boosts survival in GBM by 4 yrs
5 November 2007
Court rules for Bayer on Avelox patents
5 November 2007
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
